Nvidia–Eli Lilly Tie-Up Shows Why AI Drug Discovery Is The Next ETF Battleground

NVIDIA Corp.’s (NASDAQ:NVDA) and Eli Lilly and Co.'s (NYSE:LLY) newly announced $1 billion AI co-innovation lab underscores how artificial intelligence is spreading beyond data centers into medicine, and ETF investors are beginning to price that into thematic funds. • Roundhill Generative AI & Technology ETF stock is under selling pressure. Why is CHAT stock retreating?The partnership aims to expedite drug discovery by tightly integrating AI models with biological experimentation, and could broaden the com ...